ATE283694T1 - Neue arzneimittelkombinationen aus reboxetin und pindolol - Google Patents

Neue arzneimittelkombinationen aus reboxetin und pindolol

Info

Publication number
ATE283694T1
ATE283694T1 AT99917309T AT99917309T ATE283694T1 AT E283694 T1 ATE283694 T1 AT E283694T1 AT 99917309 T AT99917309 T AT 99917309T AT 99917309 T AT99917309 T AT 99917309T AT E283694 T1 ATE283694 T1 AT E283694T1
Authority
AT
Austria
Prior art keywords
reboxetine
pindolol
disorders
new drug
drug combinations
Prior art date
Application number
AT99917309T
Other languages
English (en)
Inventor
Duncan Paul Taylor
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Application granted granted Critical
Publication of ATE283694T1 publication Critical patent/ATE283694T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
AT99917309T 1998-05-08 1999-04-14 Neue arzneimittelkombinationen aus reboxetin und pindolol ATE283694T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8486098P 1998-05-08 1998-05-08
PCT/US1999/006523 WO1999058130A1 (en) 1998-05-08 1999-04-14 New drug combinations of a n.a.r.i., preferably reboxetine, and pindolol

Publications (1)

Publication Number Publication Date
ATE283694T1 true ATE283694T1 (de) 2004-12-15

Family

ID=22187677

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99917309T ATE283694T1 (de) 1998-05-08 1999-04-14 Neue arzneimittelkombinationen aus reboxetin und pindolol

Country Status (22)

Country Link
EP (1) EP1075264B1 (de)
JP (1) JP2002514601A (de)
KR (1) KR20010052319A (de)
CN (1) CN1300217A (de)
AT (1) ATE283694T1 (de)
AU (1) AU764579B2 (de)
BR (1) BR9909559A (de)
CA (1) CA2326105A1 (de)
DE (1) DE69922367T2 (de)
EA (1) EA003469B1 (de)
ES (1) ES2232128T3 (de)
HU (1) HUP0101341A3 (de)
IL (1) IL139211A0 (de)
NO (1) NO20005621D0 (de)
NZ (1) NZ508035A (de)
PL (1) PL345351A1 (de)
PT (1) PT1075264E (de)
SI (1) SI1075264T1 (de)
SK (1) SK14502000A3 (de)
TR (1) TR200003262T2 (de)
WO (1) WO1999058130A1 (de)
ZA (1) ZA200005301B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1459751B1 (de) * 1999-07-01 2005-09-14 Pharmacia & Upjohn Company LLC (S,S)-Reboxetin zur Behandlung von Migränekopfschmerzen
ES2246488T3 (es) * 1999-07-01 2006-02-16 PHARMACIA & UPJOHN COMPANY LLC Reboxetina para tratar la migraña.
US20040102440A1 (en) * 2002-07-01 2004-05-27 Wong Erik Ho Fong Method of promoting smoking cessation
EP1551393A4 (de) 2002-07-30 2010-06-16 Peter Migaly Kombinationstherapie gegen depression, prävention von suizid und verschiedener medizinischer und psychiatrischer erkrankungen
NZ556779A (en) 2002-12-27 2008-12-24 Otsuka Pharma Co Ltd Carbostyril derivatives and serotonin reuptake inhibitors for treatment of mood disorders
AR042806A1 (es) 2002-12-27 2005-07-06 Otsuka Pharma Co Ltd Combinacion de derivados de carboestirilo e inhibidores de la reabsorcion de serotonina para el tratamiento de trastornos del animo
US20120077818A1 (en) * 2009-05-13 2012-03-29 Sunovion Pharmaceuticals Inc. Compositions comprising transnorsertraline and serotonin receptor 1a agonists/antagonists and uses thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2134038C (en) * 1994-06-16 1997-06-03 David Taiwai Wong Potentiation of drug response
WO1997006792A1 (en) * 1995-08-16 1997-02-27 Eli Lilly And Company Potentiation of serotonin response

Also Published As

Publication number Publication date
SI1075264T1 (en) 2005-06-30
BR9909559A (pt) 2000-12-19
NO20005621L (no) 2000-11-07
SK14502000A3 (sk) 2001-05-10
NO20005621D0 (no) 2000-11-07
AU764579B2 (en) 2003-08-21
ZA200005301B (en) 2001-10-01
PT1075264E (pt) 2005-01-31
EA200001162A1 (ru) 2001-04-23
EP1075264B1 (de) 2004-12-01
WO1999058130A1 (en) 1999-11-18
DE69922367D1 (de) 2005-01-05
CN1300217A (zh) 2001-06-20
KR20010052319A (ko) 2001-06-25
DE69922367T2 (de) 2005-12-22
JP2002514601A (ja) 2002-05-21
CA2326105A1 (en) 1999-11-18
AU3546099A (en) 1999-11-29
ES2232128T3 (es) 2005-05-16
TR200003262T2 (tr) 2001-03-21
PL345351A1 (en) 2001-12-17
NZ508035A (en) 2004-02-27
HUP0101341A3 (en) 2006-07-28
EA003469B1 (ru) 2003-06-26
IL139211A0 (en) 2001-11-25
EP1075264A1 (de) 2001-02-14
HUP0101341A2 (hu) 2001-08-28

Similar Documents

Publication Publication Date Title
CL2010001292A1 (es) Compuestos derivados de 1h-benzo[d]azepina; composicion farmaceutica; utiles para el tratamiento de un trastorno seleccionado entre obesidad, hiperfagia, trastorno obsesivo compulsivo, depresion, ansiedad, abuso de sustancias, trastornos del sueño, sofocos y/o hipogonadismo (division de solicitud de patente de invencion no 375-2005).
RS20120158A3 (en) Phenyl-piperazine Derivatives As Serotonin Resorption Inhibitors
DE60020613D1 (de) (S,S)-Reboxetin zur Behandlung von Fibromyalgie und anderen somatoformen Störungen
EE200100441A (et) Monoamiinide taasomastamise inhibiitorid kesknärvisüsteemi haiguste raviks
ATE442148T1 (de) Kombinationstherapie durch glukoseresorptionshemmer und retinoid x rezeptorenmodulatoren
ATE526991T1 (de) Zusammensetzungen und ihre verwendungen für die gentherapeutische behandlung von knochenerkrankungen
ATE381323T1 (de) Pharmazeutische zusammensetzungen enthaltend flavonoide und menthol
TR200401291T4 (tr) Depresyon, obsesif kompülsif bozukluk ve psikozda kullanılmak üzre bir serotonin reuptake inhibitörü ve bir atipik antipsikotik kombinasyonu
DK1343822T3 (da) Middel til diagnosticering og behandling af CTCL
ATE269078T1 (de) Piperazin derivate, deren herstellung und deren verwendung in der behandlung von störungen des zentralnervensystems
DE60231107D1 (de) Tetrahydro-pyrazinoä1,2-aüindole für die behandlung von krankheiten des zentralnervensystems
DE69922367D1 (de) Neue arzneimittelkombinationen aus reboxetin und pindolol
NO20070914L (no) Fremgangsmater for behandling av nervesystemforstyrrelser og tilstander
DK1626720T3 (da) 4-(2-Phenylsulfanyl-phenyl)-piperidinderivater som serotonin-genoptagelseshæmmer
ATE457309T1 (de) Modulatoren von peripheren 5-ht-rezeptoren
BR0214182A (pt) Processo para a preparação de tetraidrofurano ou mistura de tetraidrofurano, e seus precursores
NO20054913L (no) Anvendelse av clustein for behandling og/eller forebyggelse av perifere nevrologiske lidelser
ATE359783T1 (de) Aroylpyrrolheteroeryl und methanole zur behandlung von störungen des zentralnervensystems
EA200400793A1 (ru) Применение ингибиторов обратного захвата норэпинефрина для лечения нарушения познавательной функции
WO2002040006A3 (en) Treatment of anxiety disorders
DK1438034T3 (da) Anvendelse af -phenyl-3-dimethylaminiopropanforbindelser til behandling af urininkontinens
DK1381614T3 (da) Antidepressive azaheterocyclylmethylderivater af 2,3-dihydro-1,4-dioxino[2,3-f]quinoxalin
BR0214060A (pt) Uso de monoidroxicarbamazepina em distúrbio afetivo e de atenção e dor neuropática
DE602004013540D1 (de) Hemmung des cd95 liganden/rezeptor-systems zur behandlung von neurologischen erkrankungen und verletzungen
NO20061425L (no) Kombinasjonen av en serotonin-reopptaksinbibitor og loxapin

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1075264

Country of ref document: EP

REN Ceased due to non-payment of the annual fee